Engineering autologous tumor cell vaccine to locally mobilize antitumor immunity in tumor surgical bed-Reference-Cited by-同舟云学术

Engineering autologous tumor cell vaccine to locally mobilize antitumor immunity in tumor surgical bed

Published:2020-06-19 Issue:25 Volume:6 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Fang Lei¹²^ORCID,Zhao Zitong¹³,Wang Jue¹,Zhang Pengcheng¹⁴^ORCID,Ding Yaping²,Jiang Yanyan³,Wang Dangge¹⁴^ORCID,Li Yaping¹⁴^ORCID

Affiliation:

1. State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

2. College of Sciences, Shanghai University, Shanghai 200444, China.

3. School of Pharmacy, Fudan University, Shanghai 201203, China.

4. Yantai Key Laboratory of Nanomedicine & Advanced Preparations, Yantai Institute of Materia Medica, Shandong 264000, China.

Abstract

A feasible and transformable cancer vaccine was designed for personalized immunotherapy of postoperative tumors.

Funder

National Natural Science Foundation of China

Chinese Academy of Sciences

Science and Technology Commission of Shanghai Municipality

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference41 articles.

1. Cancer vaccines on the move

2. The dawn of vaccines for cancer prevention

3. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

4. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment

5. Red blood cell–derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor cell loaded thermosensitive hydrogel for photodynamic therapy associated tumor antigens release;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-11

2. Regulation of tumor antigens-Dependent immunotherapy via the hybrid M1 macrophage/tumor lysates Hydrogel;Heliyon;2024-09

3. A Biomimetic Autophagosomes‐Based Nanovaccine Boosts Anticancer Immunity;Advanced Materials;2024-08-28

4. Boron Neutron Capture Therapy‐Derived Extracellular Vesicles via DNA Accumulation Boost Antitumor Dendritic Cell Vaccine Efficacy;Advanced Science;2024-07-17

5. Biomaterials-assisted cancer vaccine delivery: preclinical landscape, challenges, and opportunities;Expert Opinion on Drug Delivery;2024-07-02